| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| E921026 | 812647-88-4 | YM-08, ≥98% (HPLC) 3-Ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-2-(2-pyridinylmethylene)-4-thiazolidinone, ≥98% (HPLC) |
C19H17N3OS2 | |
| Y933260 | 1780390-65-9 | YM-244769 dihydrochloride, ≥98% YM-244769 dihydrochloride, ≥98% |
C26H24Cl2FN3O3 | |
| Y933392 | 568580-02-9 | YM-254890, 95% YM-254890, 95% |
C46H69N7O15 | |
| Y911042 | 144337-18-8 | YM-26734, 98% YM-26734, 98% |
C45H62O8 | |
| E911667 | 182959-33-7 | YM-53601, 98% 2-[(2E)-2-(1-azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethoxy]-9H-carbazole, monohydrochloride, 98% |
C21H21FN2O.HCl | |
| D937616 | 365462-23-3 | YM150, ≥99% Darexaban, ≥99% |
C27H30N4O4 | |
| Y798454 | 781661-94-7 | YM155 (Sepantronium Bromide), 10mM in DMSO YM155 (Sepantronium Bromide), 10mM in DMSO |
C20H19BrN4O3 | |
| Y911124 | 179102-65-9 | YM158 (free base) (YM-57158), 98% YM158 (free base) (YM-57158), 98% |
C32H33ClN6O5S2 | |
| Y913013 | 902589-96-2 | YMU1, 98% YMU1, 98% |
C17H22N4O4S | |
| Y933242 | 2454246-18-3 | YQ128, ≥98% YQ128, ≥98% |
C27H29ClN2O4S2 | |
| Y912995 | 89805-39-0 | YS-035 hydrochloride, 98% YS-035 hydrochloride, 98% |
C21H29NO4 • HCl | |
| Y913072 | 916482-17-2 | YS-121, 98% YS-121, 98% |
C20H26ClN3O2S | |
| Y910254 | 2131223-64-6 | YW1128, 98% YW1128, 98% |
C20H17N5O | |
| Y910255 | 2131223-69-1 | YW1159, 98% YW1159, 98% |
C19H14FN5O | |
| Y910314 | 1702816-75-8 | YY-20394, 98% YY-20394, 98% |
C28H37FN6O5S | |
| Z969394 | 1199236-64-0 | Z 944,CaV3.x阻断剂, 98% Z 944, 98% |
C19H27ClFN3O2 | |
| Z969269 | 105637-38-5 | Z-FA-FMK,不可逆半胱氨酸蛋白酶抑制剂, 98% Z-FA-FMK, 98% |
||
| Z729147 | 180313-86-4 | Z-FG-NHO-BzOME, 98% Z-FG-NHO-BzOME, 98% |
C27H27N3O7 | |
| Z910627 | 498555-58-1 | Z-IETD-pNA(GRANZYME B SUBSTRATE I), 98% Z-IETD-pNA(GRANZYME B SUBSTRATE I), 98% |
C33H42N6O13(Z-ILE-GLu-ThR-AsP-PNa) | |
| Z938301 | 524746-03-0 | Z-LEHD-FMKCaspase-9 Inhibitor, ≥98% Z-LEHD-FMK TFA, ≥98% |
C34H44F4N6O12 |